TD Asset Management Portfolio holdings
AUM
$117B
1-Year Return
25.17%
This Quarter Return
+1.82%
1 Year Return
+25.17%
3 Year Return
+87.06%
5 Year Return
+156.45%
10 Year Return
+305.53%
AUM
$113B
AUM Growth
-$291M
(-0.26%)
Cap. Flow
-$48.7M
Cap. Flow
% of AUM
-0.04%
Top 10 Holdings %
Top 10 Hldgs %
26.07%
Holding
1,436
New
51
Increased
634
Reduced
495
Closed
194
Top Buys
| 1 |
Invesco Senior Loan ETF
BKLN
|
+$392M |
| 2 |
Ares Management
ARES
|
+$226M |
| 3 |
SAP
SAP
|
+$219M |
| 4 |
Lam Research
LRCX
|
+$186M |
| 5 |
Apple
AAPL
|
+$158M |
Top Sells
| 1 |
KLA
KLAC
|
+$273M |
| 2 |
Toronto Dominion Bank
TD
|
+$247M |
| 3 |
AbbVie
ABBV
|
+$178M |
| 4 |
Intuit
INTU
|
+$109M |
| 5 |
Corebridge Financial
CRBG
|
+$99.7M |
Sector Composition
| 1 | Technology | 21.97% |
| 2 | Financials | 20.9% |
| 3 | Industrials | 10.1% |
| 4 | Healthcare | 9.35% |
| 5 | Consumer Discretionary | 7.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
HTO
1176
H2O America Common Stock
HTO
$1.76B
| $561K | ﹤0.01% |
11,400
-14,800
| -56% | -$728K |
|
|
ARMN
1177
Aris Mining
ARMN
$1.87B
| $556K | ﹤0.01% |
158,720
+14,434
| +10% | +$50.6K |
|
1178
Geron
GERN
$868M
| $547K | ﹤0.01% |
154,614
-451,600
| -74% | -$1.6M |
|
1179
Pacific Biosciences
PACB
$393M
| $536K | ﹤0.01% |
292,686
| – | – |
|
1180
Bio-Rad Laboratories Class A
BIO
$7.86B
| $535K | ﹤0.01% |
1,629
+280
| +21% | +$92K |
|
1181
Ryan Specialty Holdings
RYAN
$6.93B
| $526K | ﹤0.01% |
+8,200
| New | +$526K |
|
1182
Vanguard High Dividend Yield ETF
VYM
$64.2B
| $523K | ﹤0.01% |
+4,100
| New | +$523K |
|
1183
MakeMyTrip
MMYT
$9.31B
| $514K | ﹤0.01% |
4,577
-2,018
| -31% | -$227K |
|
1184
Ocular Therapeutix
OCUL
$2.22B
| $512K | ﹤0.01% |
60,000
-52,800
| -47% | -$451K |
|
|
GOOS
1185
Canada Goose Holdings
GOOS
$1.45B
| $501K | ﹤0.01% |
49,856
-39,245
| -44% | -$394K |
|
1186
iShares MSCI India ETF
INDA
$9.3B
| $492K | ﹤0.01% |
+9,339
| New | +$492K |
|
|
BLDP
1187
Ballard Power Systems
BLDP
$568M
| $482K | ﹤0.01% |
289,788
+8,012
| +3% | +$13.3K |
|
1188
iShares S&P 100 ETF
OEF
$22.3B
| $480K | ﹤0.01% |
+1,661
| New | +$480K |
|
1189
Blue Foundry Bancorp
BLFY
$203M
| $477K | ﹤0.01% |
48,582
+3,932
| +9% | +$38.6K |
|
1190
EyePoint Pharmaceuticals
EYPT
$941M
| $469K | ﹤0.01% |
62,946
-42,000
| -40% | -$313K |
|
1191
Alto Neuroscience
ANRO
$105M
| $469K | ﹤0.01% |
110,792
+33,800
| +44% | +$143K |
|
|
OBE
1192
Obsidian Energy
OBE
$396M
| $460K | ﹤0.01% |
79,178
+7,111
| +10% | +$41.3K |
|
1193
Westlake Corp
WLK
$11B
| $458K | ﹤0.01% |
3,998
+390
| +11% | +$44.7K |
|
1194
British American Tobacco
BTI
$123B
| $454K | ﹤0.01% |
12,494
-165
| -1% | -$5.99K |
|
1195
Knife River
KNF
$4.54B
| $447K | ﹤0.01% |
+4,400
| New | +$447K |
|
1196
National Grid
NGG
$69.8B
| $392K | ﹤0.01% |
6,787
-130
| -2% | -$7.51K |
|
1197
Orchestra BioMed
OBIO
$146M
| $371K | ﹤0.01% |
92,678
| – | – |
|
1198
Camtek
CAMT
$3.71B
| $363K | ﹤0.01% |
4,435
+273
| +7% | +$22.3K |
|
1199
iShares Russell 2000 ETF
IWM
$66.5B
| $362K | ﹤0.01% |
1,637
-37
| -2% | -$8.18K |
|
1200
Neurogene
NGNE
$278M
| $361K | ﹤0.01% |
+15,800
| New | +$361K |
|